Closure Trading Window for amalgamation of Venmax Drugs and Pharmaceuticals Limited with Hatri Pharma Private Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venmax Drugs and Pharmaceuticals Ltd has informed the stock exchanges that its trading window for dealing in company securities will remain closed with immediate effect from August 25, 2025 until the end of trading hours on September 4, 2025. The closure is due to the Board of Directors approving a proposed Scheme of Amalgamation of Hatri Pharma Private Limited (Transferor Company) with Venmax Drugs (the Company), under Sections 230-232 of the Companies Act, 2013. This restriction applies to employees and other connected persons as per the company's insider trading code under SEBI PIT Regulations, 2015. The intimation was signed by Priyanka Agarwal, Company Secretary & Compliance Officer.
Insiders, employees, and connected persons cannot trade in Venmax Drugs shares until September 4, 2025. The trading window closure signals an upcoming material corporate action — the amalgamation with Hatri Pharma — which could affect shareholding structure and warrants close monitoring by retail investors.